According to the results, the pre-treatment TF activity (AUC = 0.701, p = 0.0143) and PAI-1 (AUC = 0.659, p = 0.0472) concentration are considered to be the strongest predictors of disease relapse and may effectively predict breast cancer recurrence before the application of adjuvant therapy. This evidence concerns the gene TF and breast carcinoma.